Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes & Labels, Instruments & Software), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research), End User (CROS, Pharma) & Region - Global Forecast to 2028
The global cell-based assays market is projected to reach USD 28.2 billion by 2028 from USD 18.9 billion in 2023, at a CAGR of 8.4% during the forecast period of 2023 to 2028. The growth of this market is driven by the support and funding provided by governments for cell-based research initiatives The availability of funding for research & development activities related to cell-based research can significantly impact the development of innovative technologies and applications. In March 2020, the Government of Canada invested around USD 7.0 million through the Stem Cell Network’s competitive research funding program to support stem cell research in Canada.
“The basic research segment accounted for the second largest share by application during the forecast period”
In 2022, basic research segment accounted for the second-largest share by application in the global cell-based assays market. Basic research plays a crucial role in advancing our understanding of cellular mechanisms, disease pathways, and therapeutic targets. Cell-based assays provide valuable tools for studying cellular responses, identifying drug candidates, and evaluating their efficacy. The demand for cell-based assays in basic research is growing as researchers strive to unravel the complexities of biological processes and develop innovative solutions for various diseases. This focus on basic research applications is fueling the expansion of the cell-based assays market.
“The pharmacokinetic studies segment accounted for the second largest share of the cell based assays market by drug discovery application”
In the cell-based assays market, the pharmacokinetic studies segment holds significant importance within the drug discovery application. Pharmacokinetic studies involve the assessment of how drugs are absorbed, distributed, metabolized, and eliminated by the body. Cell-based assays play a crucial role in evaluating drug metabolism, drug-drug interactions, and the determination of drug concentrations in biological samples. These assays provide valuable insights into the pharmacokinetic properties of potential drug candidates, allowing researchers to optimize dosage regimens and enhance therapeutic outcomes. The growing emphasis on personalized medicine and precision dosing further drives the demand for pharmacokinetic studies using cell-based assays. With their ability to mimic physiological conditions and provide accurate drug response data, cell-based assays have become indispensable tools in pharmacokinetic research, contributing to the overall growth of the cell-based assays market
“Europe: The second largest region in the cell-based assays market”
Europe is the second-largest market for cell-based assays after North America. The European market comprises the UK, Germany, France, Spain, Italy, and the Rest of Europe (RoE). Factors such as rising government investments in life science research and the increasing focus on stem cell research and regenerative medicine drive market growth. Moreover, several conferences, symposia, seminars, trade fairs, annual events, and workshops are being organized in Europe to create awareness of cell-based assay products.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the cell-based assays market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
“The basic research segment accounted for the second largest share by application during the forecast period”
In 2022, basic research segment accounted for the second-largest share by application in the global cell-based assays market. Basic research plays a crucial role in advancing our understanding of cellular mechanisms, disease pathways, and therapeutic targets. Cell-based assays provide valuable tools for studying cellular responses, identifying drug candidates, and evaluating their efficacy. The demand for cell-based assays in basic research is growing as researchers strive to unravel the complexities of biological processes and develop innovative solutions for various diseases. This focus on basic research applications is fueling the expansion of the cell-based assays market.
“The pharmacokinetic studies segment accounted for the second largest share of the cell based assays market by drug discovery application”
In the cell-based assays market, the pharmacokinetic studies segment holds significant importance within the drug discovery application. Pharmacokinetic studies involve the assessment of how drugs are absorbed, distributed, metabolized, and eliminated by the body. Cell-based assays play a crucial role in evaluating drug metabolism, drug-drug interactions, and the determination of drug concentrations in biological samples. These assays provide valuable insights into the pharmacokinetic properties of potential drug candidates, allowing researchers to optimize dosage regimens and enhance therapeutic outcomes. The growing emphasis on personalized medicine and precision dosing further drives the demand for pharmacokinetic studies using cell-based assays. With their ability to mimic physiological conditions and provide accurate drug response data, cell-based assays have become indispensable tools in pharmacokinetic research, contributing to the overall growth of the cell-based assays market
“Europe: The second largest region in the cell-based assays market”
Europe is the second-largest market for cell-based assays after North America. The European market comprises the UK, Germany, France, Spain, Italy, and the Rest of Europe (RoE). Factors such as rising government investments in life science research and the increasing focus on stem cell research and regenerative medicine drive market growth. Moreover, several conferences, symposia, seminars, trade fairs, annual events, and workshops are being organized in Europe to create awareness of cell-based assay products.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80% and Demand Side 20%
- By Designation: C-level - 45%, D-level - 30%, and Others - 25%
- By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
- Danaher Corporation (US)
- Thermo Fisher Scientific, Inc. (US)
- Merck KGaA (Germany)
- Becton, Dickinson and Company (US)
- Lonza (Switzerland)
- PerkinElmer (US)
- Charles River Laboratories (US)
- Eurofins Scientific (France)
- Enzo Biochem (US)
- Carna Biosciences (Japan)
- Cell Biolabs (US)
- Promega Corporation (US)
- Cell Signaling Technology (US)
- BioAgilytix Labs (US)
- Reaction Biology Corporation (US)
- AAT Bioquest (US)
- Pestka Biomedical Laboratories (US)
- InvivoGen (US), CA3 Biosciences (US)
- BPS Bioscience (US)
- BellBrook Labs (US)
- Profacgen (US)
- BMG LABTECH (Germany)
- Hanugen Therapeutics (India)
- JRS Pharma (Germany)
This report provides a detailed picture of the cell-based assays market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
- Analysis of key drivers (growing demand for drug discovery & development and the increasing preference for cell-based assays in drug discovery, the growing government support and funding for cell- based research, and the rising efforts by the FDA to curtail animal-based studies), restraints (high cost of instruments and restrictions imposed by product end-user licenses for reagents, lack of standardization of protocols used in cell-based assays), opportunities (growing applications of cell-based assays in chronic diseases and personalized medicine, growing opportunities in emerging economies), and challenges (complexities in assay designs) influencing the growth of the market.
- Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the cell-based assays market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the cell-based assays market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Lonza (Switzerland), PerkinElmer (US), Charles River Laboratories (US), Eurofins Scientific (France), Enzo Biochem (US), Carna Biosciences (Japan), Cell Biolabs (US), Promega Corporation (US), Cell Signaling Technology (US), BioAgilytix Labs (US), Reaction Biology Corporation (US), AAT Bioquest (US), Pestka Biomedical Laboratories (US), InvivoGen (US), CA3 Biosciences (US), BPS Bioscience (US), BellBrook Labs (US), Profacgen (US), BMG LABTECH (Germany), Hanugen Therapeutics (India), and JRS Pharma (Germany) and among others in the market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF ECONOMIC RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 CELL-BASED ASSAYS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
FIGURE 4 APPROACH 1: MARKET SIZE ESTIMATION – COMPANY REVENUE ANALYSIS (2022)
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 CELL-BASED ASSAYS MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 7 CELL-BASED ASSAYS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.3.1 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 IMPACT OF RECESSION ON CELL-BASED ASSAYS MARKET
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 9 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 CELL-BASED ASSAYS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET
4 PREMIUM INSIGHTS
4.1 CELL-BASED ASSAYS MARKET OVERVIEW
FIGURE 13 RISING DRUG DISCOVERY ACTIVITY TO DRIVE DEMAND FOR CELL-BASED ASSAYS
4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET SHARE (2022)
FIGURE 14 CONSUMABLES COMMANDED LARGEST SHARE OF NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2022
4.3 CELL-BASED ASSAYS MARKET SHARE, BY APPLICATION, 2022 VS. 2028
FIGURE 15 DRUG DISCOVERY SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 CELL-BASED ASSAYS MARKET SHARE, BY END USER (2022)
FIGURE 16 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
5.2.1.2 Government support and funding for cell-based research
TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019–2021 (USD MILLION)
5.2.1.3 Growing efforts by FDA to curtail animal-based studies
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents
5.2.2.2 Lack of standardization of protocols used in cell-based assays
5.2.3 OPPORTUNITIES
5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine
5.2.3.2 Growing opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Complexities in assay designs
5.3 IMPACT OF UNCERTAINTIES ON CELL-BASED ASSAYS MARKET
FIGURE 19 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR CELL-BASED ASSAY PRODUCT PROVIDERS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
TABLE 4 PRICE OF CELL-BASED ASSAY PRODUCTS, BY KEY PLAYER
5.5.2 AVERAGE SELLING PRICE TREND
5.6 VALUE CHAIN ANALYSIS
FIGURE 21 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 22 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
FIGURE 23 CELL-BASED ASSAYS MARKET: ECOSYSTEM ANALYSIS
TABLE 5 SUPPLY CHAIN ECOSYSTEM
5.9 TECHNOLOGY ANALYSIS
5.9.1 FLOW CYTOMETRY
5.9.2 HIGH-THROUGHPUT SCREENING (HTS) TECHNOLOGY
5.9.3 HIGH-CONTENT SCREENING (HCS)
5.9.4 LABEL-FREE DETECTION
5.10 REGULATORY ANALYSIS
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 CELL-BASED ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF BUYERS
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY CONFERENCES & EVENTS, 2022–2023
TABLE 7 CELL-BASED ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAYS
5.13.2 BUYING CRITERIA FOR CELL-BASED ASSAYS
FIGURE 25 KEY BUYING CRITERIA FOR END USERS
5.14 PATENT ANALYSIS
FIGURE 26 PATENT APPLICATIONS FOR CELL-BASED ASSAYS MARKET, JANUARY 2013–JUNE 2023
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 8 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 CONSUMABLES
TABLE 9 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 10 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 11 EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 12 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 13 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
6.2.1 REAGENTS
6.2.1.1 High demand for reagents in research applications to propel market growth
TABLE 16 CELL-BASED ASSAYS MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 ASSAY KITS
TABLE 22 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
6.2.2.1 Reporter gene assays
6.2.2.1.1 Versatility of reporter gene assays and widespread applications in various fields to fuel growth
TABLE 29 REPORTER GENE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.2 Cell growth assays
6.2.2.2.1 Growing applications of cell viability and cell proliferation assays for assessing cell growth to boost market
TABLE 35 CELL GROWTH ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.3 Second messenger assays
6.2.2.3.1 Growing use of second messenger assays to study cell signaling to fuel growth
TABLE 41 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 42 NORTH AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 EUROPE: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 ASIA PACIFIC: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 LATIN AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.4 Cell death assays
6.2.2.4.1 Importance of cell death quantification in drug development to favor growth
TABLE 47 CELL DEATH ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.5 Other assay kits
TABLE 53 OTHER ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 55 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 MICROPLATES
6.2.3.1 Growing demand for microplates in assay development to propel growth
TABLE 59 CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 CELL LINES
TABLE 65 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
6.2.4.1 Immortalized cell lines
6.2.4.1.1 Wide use of immortalized cell lines to boost market
TABLE 72 IMMORTALIZED CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 76 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4.2 Primary cell lines
6.2.4.2.1 Valuable tools for cell-based assays to boost demand for primary cell lines
TABLE 78 PRIMARY CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 79 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 MIDDLE EAST & AFRICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4.3 Stem cell lines
6.2.4.3.1 Use of stem cell lines to model wide variety of tissues and diseases to fuel adoption
TABLE 84 STEM CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 PROBES & LABELS
6.2.5.1 Growing need of effective labeling of cells to study cellular events to boost demand
TABLE 90 CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.6 OTHER CONSUMABLES
TABLE 96 CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS & SOFTWARE
6.3.1 AUTOMATION IN INSTRUMENTS ALONG WITH ADOPTION OF SOFTWARE TO DRIVE SEGMENTAL GROWTH
TABLE 102 CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH
TABLE 108 CELL-BASED ASSAYS MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 CELL-BASED ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 114 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 DRUG DISCOVERY
TABLE 115 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 119 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 TOXICITY STUDIES
7.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth
TABLE 122 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 123 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 PHARMACOKINETIC STUDIES
7.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays
TABLE 128 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.3 PHARMACODYNAMIC STUDIES
7.2.3.1 Advantages of cell-based assays in studying pharmacodynamics to propel growth
TABLE 134 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 BASIC RESEARCH
7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
TABLE 140 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 141 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 145 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 146 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 147 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 CELL-BASED ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 152 CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
8.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 27 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
TABLE 153 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 154 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 155 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 156 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.3.1 GROWING DEMAND FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS
TABLE 159 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 160 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 161 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 162 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING FOCUS OF ACADEMIC INSTITUTIONS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE DEMAND
TABLE 165 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 CELL-BASED ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 171 CELL-BASED ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
TABLE 172 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 174 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 178 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 US to dominate North American cell-based assays market during forecast period
TABLE 180 US: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 181 US: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 US: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 US: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 185 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 US: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Strategic partnerships and collaborations to drive market in Canada
TABLE 187 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 188 CANADA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 CANADA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 CANADA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 192 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 194 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 195 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 196 EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 200 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Germany to dominate cell-based assays market in Europe during forecast period
TABLE 202 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 203 GERMANY: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 GERMANY: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 GERMANY: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 207 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Growing cancer research funding to increase demand for cell-based assays
TABLE 209 UK: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 210 UK: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 UK: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 UK: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 214 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Growing biotechnology sector to drive growth
TABLE 216 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 217 FRANCE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 FRANCE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 FRANCE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 221 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Growing pharmaceutical industry in Italy to boost market
TABLE 223 ITALY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 224 ITALY: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 225 ITALY: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 ITALY: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 228 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Public-private partnerships and expansions of pharmaceutical companies in Spain to favor market growth
TABLE 230 SPAIN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 231 SPAIN: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 SPAIN: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 SPAIN: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 235 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 237 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 238 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 239 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 243 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
TABLE 244 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 245 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 246 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 249 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 250 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 CHINA
9.4.2.1 Robust pharma industry and presence of key CROs to favor market growth
TABLE 252 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 253 CHINA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 CHINA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 CHINA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 257 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 258 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Government initiatives for drug innovation to support market growth
TABLE 259 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 260 JAPAN: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 JAPAN: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 262 JAPAN: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 263 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 264 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing investments in R&D and funding for life science research to propel market
TABLE 266 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 267 INDIA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 INDIA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 INDIA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 271 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 273 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 274 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 275 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 278 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 279 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
TABLE 280 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 281 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 282 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 285 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 286 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 287 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 LATIN AMERICA: RECESSION IMPACT
9.5.2 BRAZIL
9.5.2.1 Growing research & development activities to support market growth
TABLE 288 BRAZIL: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 289 BRAZIL: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 BRAZIL: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 BRAZIL: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 293 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 294 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 295 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 296 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 298 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 299 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 300 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 302 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 303 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 304 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 307 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 308 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
9.6.2 MIDDLE EAST
9.6.2.1 Growing prevalence of chronic diseases in Middle East to boost growth
TABLE 310 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 311 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 313 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 314 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 315 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 316 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.3 AFRICA
9.6.3.1 Government initiatives to drive research & development in Africa
TABLE 317 AFRICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 318 AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 321 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 322 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 323 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 30 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-BASED ASSAYS MARKET, JANUARY 2020–JUNE 2023
10.3 MARKET SHARE ANALYSIS
FIGURE 31 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 324 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 33 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT, 2022
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 34 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
10.6.4.1 Competitive benchmarking of start-ups/SME players
TABLE 325 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 326 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
10.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
10.7.1 COMPANY FOOTPRINT (25 COMPANIES)
TABLE 327 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7.2 PRODUCT & SERVICE FOOTPRINT (25 COMPANIES)
TABLE 328 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7.3 REGIONAL FOOTPRINT (25 COMPANIES)
TABLE 329 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
10.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 330 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2020–JUNE 2023
TABLE 331 CELL-BASED ASSAYS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020–JUNE 2023
TABLE 332 CELL-BASED ASSAYS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 DANAHER CORPORATION
TABLE 333 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.2 THERMO FISHER SCIENTIFIC
TABLE 334 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
11.1.3 MERCK KGAA
TABLE 335 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 37 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.4 BECTON, DICKINSON AND COMPANY
TABLE 336 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
11.1.5 LONZA GROUP
TABLE 337 LONZA GROUP: BUSINESS OVERVIEW
FIGURE 39 LONZA GROUP: COMPANY SNAPSHOT (2022)
11.1.6 PERKINELMER, INC.
TABLE 338 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
11.1.7 CHARLES RIVER LABORATORIES
TABLE 339 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
FIGURE 41 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
11.1.8 EUROFINS SCIENTIFIC SE
TABLE 340 EUROFINS SCIENTIFIC SE: BUSINESS OVERVIEW
FIGURE 42 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022)
11.1.9 ENZO BIOCHEM, INC.
TABLE 341 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
FIGURE 43 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2022)
11.1.10 CARNA BIOSCIENCES, INC.
TABLE 342 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW
FIGURE 44 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 CELL BIOLABS, INC.
11.2.2 PROMEGA CORPORATION
11.2.3 CELL SIGNALING TECHNOLOGY, INC.
11.2.4 BIOAGILYTIX
11.2.5 REACTION BIOLOGY CORPORATION
11.2.6 AAT BIOQUEST
11.2.7 PESTKA BIOMEDICAL LABORATORIES, INC
11.2.8 INVIVOGEN
11.2.9 CA3 BIOSCIENCES, INC
11.2.10 BPS BIOSCIENCE, INC.
11.2.11 BELLBROOK LABS, INC.
11.2.12 PROFACGEN
11.2.13 BMG LABTECH
11.2.14 HANUGEN THERAPEUTICS
11.2.15 JRS PHARMA
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF ECONOMIC RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 CELL-BASED ASSAYS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
FIGURE 4 APPROACH 1: MARKET SIZE ESTIMATION – COMPANY REVENUE ANALYSIS (2022)
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 CELL-BASED ASSAYS MARKET (SUPPLY SIDE): CAGR PROJECTIONS
FIGURE 7 CELL-BASED ASSAYS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.3.1 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 IMPACT OF RECESSION ON CELL-BASED ASSAYS MARKET
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 9 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 11 CELL-BASED ASSAYS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET
4 PREMIUM INSIGHTS
4.1 CELL-BASED ASSAYS MARKET OVERVIEW
FIGURE 13 RISING DRUG DISCOVERY ACTIVITY TO DRIVE DEMAND FOR CELL-BASED ASSAYS
4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET SHARE (2022)
FIGURE 14 CONSUMABLES COMMANDED LARGEST SHARE OF NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2022
4.3 CELL-BASED ASSAYS MARKET SHARE, BY APPLICATION, 2022 VS. 2028
FIGURE 15 DRUG DISCOVERY SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
4.4 CELL-BASED ASSAYS MARKET SHARE, BY END USER (2022)
FIGURE 16 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
5.2.1.2 Government support and funding for cell-based research
TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019–2021 (USD MILLION)
5.2.1.3 Growing efforts by FDA to curtail animal-based studies
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents
5.2.2.2 Lack of standardization of protocols used in cell-based assays
5.2.3 OPPORTUNITIES
5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine
5.2.3.2 Growing opportunities in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Complexities in assay designs
5.3 IMPACT OF UNCERTAINTIES ON CELL-BASED ASSAYS MARKET
FIGURE 19 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR CELL-BASED ASSAY PRODUCT PROVIDERS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS
TABLE 4 PRICE OF CELL-BASED ASSAY PRODUCTS, BY KEY PLAYER
5.5.2 AVERAGE SELLING PRICE TREND
5.6 VALUE CHAIN ANALYSIS
FIGURE 21 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 22 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
FIGURE 23 CELL-BASED ASSAYS MARKET: ECOSYSTEM ANALYSIS
TABLE 5 SUPPLY CHAIN ECOSYSTEM
5.9 TECHNOLOGY ANALYSIS
5.9.1 FLOW CYTOMETRY
5.9.2 HIGH-THROUGHPUT SCREENING (HTS) TECHNOLOGY
5.9.3 HIGH-CONTENT SCREENING (HCS)
5.9.4 LABEL-FREE DETECTION
5.10 REGULATORY ANALYSIS
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 CELL-BASED ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF BUYERS
5.11.4 BARGAINING POWER OF SUPPLIERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY CONFERENCES & EVENTS, 2022–2023
TABLE 7 CELL-BASED ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAYS
5.13.2 BUYING CRITERIA FOR CELL-BASED ASSAYS
FIGURE 25 KEY BUYING CRITERIA FOR END USERS
5.14 PATENT ANALYSIS
FIGURE 26 PATENT APPLICATIONS FOR CELL-BASED ASSAYS MARKET, JANUARY 2013–JUNE 2023
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 8 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 CONSUMABLES
TABLE 9 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 10 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 11 EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 12 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 13 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 15 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
6.2.1 REAGENTS
6.2.1.1 High demand for reagents in research applications to propel market growth
TABLE 16 CELL-BASED ASSAYS MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 17 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 18 EUROPE: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 ASSAY KITS
TABLE 22 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 28 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
6.2.2.1 Reporter gene assays
6.2.2.1.1 Versatility of reporter gene assays and widespread applications in various fields to fuel growth
TABLE 29 REPORTER GENE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 33 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.2 Cell growth assays
6.2.2.2.1 Growing applications of cell viability and cell proliferation assays for assessing cell growth to boost market
TABLE 35 CELL GROWTH ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.3 Second messenger assays
6.2.2.3.1 Growing use of second messenger assays to study cell signaling to fuel growth
TABLE 41 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 42 NORTH AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 EUROPE: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 ASIA PACIFIC: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 LATIN AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.4 Cell death assays
6.2.2.4.1 Importance of cell death quantification in drug development to favor growth
TABLE 47 CELL DEATH ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2.5 Other assay kits
TABLE 53 OTHER ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 54 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 55 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 MICROPLATES
6.2.3.1 Growing demand for microplates in assay development to propel growth
TABLE 59 CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 CELL LINES
TABLE 65 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
6.2.4.1 Immortalized cell lines
6.2.4.1.1 Wide use of immortalized cell lines to boost market
TABLE 72 IMMORTALIZED CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 76 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4.2 Primary cell lines
6.2.4.2.1 Valuable tools for cell-based assays to boost demand for primary cell lines
TABLE 78 PRIMARY CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 79 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 81 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 MIDDLE EAST & AFRICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4.3 Stem cell lines
6.2.4.3.1 Use of stem cell lines to model wide variety of tissues and diseases to fuel adoption
TABLE 84 STEM CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 PROBES & LABELS
6.2.5.1 Growing need of effective labeling of cells to study cellular events to boost demand
TABLE 90 CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY REGION, 2021–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.6 OTHER CONSUMABLES
TABLE 96 CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSTRUMENTS & SOFTWARE
6.3.1 AUTOMATION IN INSTRUMENTS ALONG WITH ADOPTION OF SOFTWARE TO DRIVE SEGMENTAL GROWTH
TABLE 102 CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 EUROPE: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 106 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH
TABLE 108 CELL-BASED ASSAYS MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 111 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 112 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7 CELL-BASED ASSAYS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 114 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
7.2 DRUG DISCOVERY
TABLE 115 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 116 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 119 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 121 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 TOXICITY STUDIES
7.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth
TABLE 122 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 123 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 126 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 PHARMACOKINETIC STUDIES
7.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays
TABLE 128 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 129 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 132 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.3 PHARMACODYNAMIC STUDIES
7.2.3.1 Advantages of cell-based assays in studying pharmacodynamics to propel growth
TABLE 134 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 135 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 136 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 BASIC RESEARCH
7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
TABLE 140 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 141 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 142 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 145 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 146 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 147 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8 CELL-BASED ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 152 CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
8.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 27 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
TABLE 153 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 154 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 155 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 156 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 157 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 158 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.3.1 GROWING DEMAND FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS
TABLE 159 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 160 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 161 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 162 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 163 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING FOCUS OF ACADEMIC INSTITUTIONS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE DEMAND
TABLE 165 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 166 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 CELL-BASED ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 171 CELL-BASED ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
TABLE 172 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 173 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 174 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 178 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 179 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 NORTH AMERICA: RECESSION IMPACT
9.2.2 US
9.2.2.1 US to dominate North American cell-based assays market during forecast period
TABLE 180 US: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 181 US: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 US: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 US: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 185 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 US: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Strategic partnerships and collaborations to drive market in Canada
TABLE 187 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 188 CANADA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 CANADA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 CANADA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 192 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 194 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 195 EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 196 EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 200 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 201 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 EUROPE: RECESSION IMPACT
9.3.2 GERMANY
9.3.2.1 Germany to dominate cell-based assays market in Europe during forecast period
TABLE 202 GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 203 GERMANY: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 GERMANY: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 GERMANY: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 207 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Growing cancer research funding to increase demand for cell-based assays
TABLE 209 UK: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 210 UK: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 UK: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 UK: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 214 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Growing biotechnology sector to drive growth
TABLE 216 FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 217 FRANCE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 218 FRANCE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 FRANCE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 221 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 222 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Growing pharmaceutical industry in Italy to boost market
TABLE 223 ITALY: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 224 ITALY: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 225 ITALY: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 ITALY: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 228 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Public-private partnerships and expansions of pharmaceutical companies in Spain to favor market growth
TABLE 230 SPAIN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 231 SPAIN: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 232 SPAIN: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 SPAIN: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 235 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 237 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 238 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 239 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 242 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 243 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
TABLE 244 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 245 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 246 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 249 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 250 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 ASIA PACIFIC: RECESSION IMPACT
9.4.2 CHINA
9.4.2.1 Robust pharma industry and presence of key CROs to favor market growth
TABLE 252 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 253 CHINA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 254 CHINA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 255 CHINA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 257 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 258 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Government initiatives for drug innovation to support market growth
TABLE 259 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 260 JAPAN: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 JAPAN: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 262 JAPAN: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 263 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 264 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 265 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Increasing investments in R&D and funding for life science research to propel market
TABLE 266 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 267 INDIA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 INDIA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 269 INDIA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 271 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 273 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 274 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 275 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 278 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 279 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
TABLE 280 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 281 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 282 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 283 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 284 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 285 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 286 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 287 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 LATIN AMERICA: RECESSION IMPACT
9.5.2 BRAZIL
9.5.2.1 Growing research & development activities to support market growth
TABLE 288 BRAZIL: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 289 BRAZIL: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 BRAZIL: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 BRAZIL: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 293 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 294 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 295 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 296 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 298 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 299 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 300 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
TABLE 302 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 303 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 304 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 305 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 307 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 308 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 309 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
9.6.2 MIDDLE EAST
9.6.2.1 Growing prevalence of chronic diseases in Middle East to boost growth
TABLE 310 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 311 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 313 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 314 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 315 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 316 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.3 AFRICA
9.6.3.1 Government initiatives to drive research & development in Africa
TABLE 317 AFRICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 318 AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 320 AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 321 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 322 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 323 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 30 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-BASED ASSAYS MARKET, JANUARY 2020–JUNE 2023
10.3 MARKET SHARE ANALYSIS
FIGURE 31 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
TABLE 324 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 33 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT, 2022
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 34 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022
10.6.4.1 Competitive benchmarking of start-ups/SME players
TABLE 325 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 326 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
10.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
10.7.1 COMPANY FOOTPRINT (25 COMPANIES)
TABLE 327 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7.2 PRODUCT & SERVICE FOOTPRINT (25 COMPANIES)
TABLE 328 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7.3 REGIONAL FOOTPRINT (25 COMPANIES)
TABLE 329 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
10.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 330 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2020–JUNE 2023
TABLE 331 CELL-BASED ASSAYS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020–JUNE 2023
TABLE 332 CELL-BASED ASSAYS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 DANAHER CORPORATION
TABLE 333 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.2 THERMO FISHER SCIENTIFIC
TABLE 334 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
11.1.3 MERCK KGAA
TABLE 335 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 37 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.4 BECTON, DICKINSON AND COMPANY
TABLE 336 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
11.1.5 LONZA GROUP
TABLE 337 LONZA GROUP: BUSINESS OVERVIEW
FIGURE 39 LONZA GROUP: COMPANY SNAPSHOT (2022)
11.1.6 PERKINELMER, INC.
TABLE 338 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
11.1.7 CHARLES RIVER LABORATORIES
TABLE 339 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
FIGURE 41 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
11.1.8 EUROFINS SCIENTIFIC SE
TABLE 340 EUROFINS SCIENTIFIC SE: BUSINESS OVERVIEW
FIGURE 42 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022)
11.1.9 ENZO BIOCHEM, INC.
TABLE 341 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
FIGURE 43 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2022)
11.1.10 CARNA BIOSCIENCES, INC.
TABLE 342 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW
FIGURE 44 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 CELL BIOLABS, INC.
11.2.2 PROMEGA CORPORATION
11.2.3 CELL SIGNALING TECHNOLOGY, INC.
11.2.4 BIOAGILYTIX
11.2.5 REACTION BIOLOGY CORPORATION
11.2.6 AAT BIOQUEST
11.2.7 PESTKA BIOMEDICAL LABORATORIES, INC
11.2.8 INVIVOGEN
11.2.9 CA3 BIOSCIENCES, INC
11.2.10 BPS BIOSCIENCE, INC.
11.2.11 BELLBROOK LABS, INC.
11.2.12 PROFACGEN
11.2.13 BMG LABTECH
11.2.14 HANUGEN THERAPEUTICS
11.2.15 JRS PHARMA
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
